Summary

Clinical Nutrition Market By Product Type (Oral Clinical Nutrition, Parenteral Nutrition {Carbohydrates, Parenteral Lipid Emulsion, Single Dose Amino Acid Solutions, Trace Elements, Vitamins & Minerals}, Enteral Feeding Formulas {Standard Formula, Disease-specific Formulas}), By Application (Alzheimer’s Disease, Nutrition Deficiency, Cancer Care, Diabetes, Chronic Kidney Diseases, Orphan Diseases, Dysphagia, Pain Management, Malabsorption/GI Disorder/Diarrhea, and Others), By Age Group (Pediatric, Adult, Geriatrics) And By End User (Hospitals, Retail Pharmacies, Online Pharmacies and Others), Global Market Size, Segmental analysis, Regional Overview, Company share analysis, Leading Company Profiles And Market Forecast, 2025 ? 2035
The Clinical Nutrition Market accounted for USD 53.8 Billion in 2024 and is expected to reach USD 98.0 Billion by 2034, growing at a CAGR of around 5.6% between 2024 and 2035. The field of clinical nutrition is the development and marketing of nutritional products intended to support specific disease states, be it by oral administration, enteral (tube feeding), or parenteral (intravenous) routes. These products have been very important in managing malnutrition, chronic diseases, post-surgical recovery, and nutritional deficiencies in the elderly. Market growth is steady due to increased awareness regarding the healthcare sector, the overall increase in senior citizens and growing prevalence of chronic and lifestyle-related diseases, and even due to the advancements made in technology and shift towards personalized nutrition to innovate and create new avenues. The outlook is positive, although investment and product diversification will keep on growing, as home healthcare services are expanding and preventive care is given more attention. The clinical nutrition market has a great future in integrating nutrition into mainstream health care practices.
Increased Demand for Nutritional Considerations in Chronic Disease Management
The increasing incidence of chronic conditions, such as diabetes, cancer, and cardiovascular diseases, has heightened the demand for nutritional support. Clinical nutrition has become an integral part of the management of these diseases by improving patient outcomes and shortening hospital stays. These days, an increasing number of healthcare providers are willing to incorporate nutritional therapy into the treatment protocols for their patients, taking cognizance of the value of nutritional therapy for disease management. This trend is being further corroborated by increasing documentation of research that stresses the role of nutrition in the care of chronic disease. With the growing awareness, clinical nutrition is poised for further integration into the standard of care. Thus, increased investments and innovations are being witnessed in the market to respond to this demand. Nutrition and medical care are thus becoming a pivotal point in chronic disease management.
Emerging Economies Have Limited Knowledge
There exists unawareness among emerging regions regarding the benefits of clinical nutrition. Healthcare providers as well as patients have very flimsy knowledge regarding the nutritional support in dealing with diseases and undergoing treatment. This knowledge gap has resulted in underuse of clinical nutrition products and lack of penetration into the market. Cultural beliefs and traditional feeding habits tend to affect the acceptance of such products. Education efforts, not only for healthcare professionals but also for the public, will go a long way in bridging the divide. By facilitating awareness campaigns through partnership and networking between government, NGOs, and industry players, availing this restraint will make the unlocking of market potential in the region.
Ambit for Home-Based Healthcare Services
Home-based health care is an effective opportunity for the clinical nutrition market. Patients recovering from surgeries or chronic conditions seek comfort from their homes and find it necessary to have nutrition solutions readily available. Home applications such as ready-to-drink formulas under clinical nutrition are gaining popularity. This is also spurred by the telemedicine advancement and remote patient monitoring. For example, providers are now able to dispense nutrition advice virtually, allowing for a more expanded reach to the patient population. Thus, it seems natural that any company producing convenient and accessible nutrition products for the home would capture this early advantage. Hence, with the ever-changing concept between home healthcare and clinical nutrition, patient care models are shifting.
Segment Analysis
Clinical nutrition supports patients with malnutrition due to cancer treatments such as chemotherapy and radiation that can hamper appetite and nutrient absorption. Diabetes is one example of metabolic disorders where specific nutrition could regulate blood sugar and prevent complications. Gastrointestinal disorders in the first place may give rise to malabsorption, requiring specialized nutrient formulations to provide adequate nutrient intake. Each application area requires specialized nutritional strategies to address the peculiar challenges posed by the condition. The development of disease-specific formulas to address the needs is extremely important. Clinical nutrition aims at improving the efficacy of treatment and the quality of life of patients. Ongoing research will build on this nutritional intervention to improve outcomes.
Hospitals are the primary clinical nutrition users, providing it for inpatients requiring nutritional support toward full recovery. Retail pharmacies provide over-the-counter clinical nutrition products so that the wider population can have access for preventive and maintenance purposes. Online pharmacies offer a convenient way of getting clinical nutrition products, particularly for those who cannot leave their homes or for people who live in remote areas where pharmacies might not be available. Each channel of distribution satisfies the different needs and preferences of the consumers. Therefore, internet-based commerce has completely changed the ability to reach consumers with clinical nutrition products. Manufacturers and distributors are following suit to make their products readily available through these channels in order to ensure customer satisfaction. Guaranteeing quality and genuineness along all channels is a priority.
Regional Analysis
North America is an important entity in the Clinical Nutrition Market, with well-developed healthcare infrastructure and increased awareness regarding nutritional therapies. Besides the large investments in healthcare and research, which foster innovations in clinical nutrition products, the aging of the population and incidence of chronic disorders further increase the demand for specialized nutrition. Regulatory provisions assist the approval of new nutritional products on a safety and efficacy basis. The presence of several prominent market players in the region ensures the availability of a variety of products. Clinical nutrition is also made more accessible to patients through insurance coverage and reimbursement policies. Continued public health education further serves to highlight the importance of nutrition to the management of diseases.
Competitive Landscape
The Clinical Nutrition Market is shared between the major players globally and local ones. These are the reasons why competition is so pronounced within the market structure. Companies such as Abbott Laboratories, Nestle Health Science, and Danone have the biggest market shares due to their broad product lines as well as a good system of distribution. Furthermore, these companies spend huge amounts of capital on research and development so that they can come up with new innovations to meet new wants from customers. They combine that with mergers and acquisitions in order to increase their geographical and capability footprint in the industry. Danone, for instance, acquired ProMedica to strengthen its home care nutrition services. Most emerging competitors focus on new niches, from which they offer specialized products. The competitive environment is therefore always constantly changing, as every company aims at a balance between quality and affordability and making it accessible to all in its quest to increase or maintain share within the market.
Report Coverage:
By Product Type
- Oral Clinical Nutrition
- Parenteral Nutrition
- Carbohydrates
- Parenteral Lipid Emulsion
- Single Dose Amino Acid Solutions
- Trace Elements
- Vitamins & Minerals
- Enteral Feeding Formulas
- Standard Formula
- Disease-specific Formulas
By Application
- Alzheimer’s Disease
- Nutrition Deficiency
- Cancer Care, Diabetes
- Chronic Kidney Diseases
- Orphan Diseases
- Dysphagia
- Pain Management
- Digestive Malfunction/Intestinal Disorder/Diarrheal Conditions
- Others
By Age Group
- Pediatric
- Adult
- Geriatrics
By End User
- Hospitals
- Retail Pharmacies
- Online Pharmacies
- Others

ページTOPに戻る

Table of Contents

Table of Contents
1. Methodology & Report Coverage
1.1. Definition & Objective
1.2. Market Evaluation & forecast parameter
1.3. Research Methodology
1.4. Data Validation Sources
1.4.1. Secondary Research
1.4.2. Primary Research
2. Market Overview
3. Global Clinical Nutrition Market: Market Dynamics
3.1. Executive Summary
3.2. Market Driving Factors
3.2.1. Growing prevalence of chronic diseases like diabetes, cardiovascular issues, and obesity
3.2.2. Increasing aging global population and age-related health concerns.
3.2.3. Rising awareness among consumers and healthcare professionals about the role of nutrition in disease prevention and management
3.3. Key industry pitfalls & challenges
3.3.1. Expensive clinical nutrition may limit its accessibility to certain patient populations, particularly in low-income regions or countries.
3.3.2. Stringent regulations and varying approval processes across different regions.
3.3.3. Safety and quality of clinical nutrition products
3.4. Market Opportunities
3.4.1. Expensive clinical nutrition may limit its accessibility to certain patient populations, particularly in low-income regions or countries.
3.4.2. Stringent regulations and varying approval processes across different regions.
3.4.3. Safety and quality of clinical nutrition products
3.5. Porter’s Five Forces Analysis
3.6. PESTLE Analysis
3.7. Regulatory landscape
3.8. Pipeline Analysis
3.9. ESG Scenario
3.10. Competitive landscape
3.10.1. Company Market Share
3.10.2. Market Positioning
3.10.3. Strategy framework
3.10.4. Recent Acquisitions & Mergers
4. Clinical Nutrition Market, Product Type Segment Analysis
4.1. Overview Dynamics
4.1.1. Market Revenue Share, By Product Type, 2025 & 2035
4.1.2. Key Market Trends, Growth Factors, & Opportunities
4.1. Oral Clinical Nutrition
4.1.1. Market Size and Forecast, By 2025-2035 (USD Billion)
4.2. Parenteral Nutrition
4.2.1. Market Size and Forecast, By 2025-2035 (USD Billion)
4.2.2. Carbohydrates
4.2.2.1. Market Size and Forecast, By 2025-2035 (USD Billion)
4.2.3. Parenteral Lipid Emulsion
4.2.3.1. Market Size and Forecast, By 2025-2035 (USD Billion)
4.2.4. Single-Dose Amino Acid Solutions
4.2.4.1. Market Size and Forecast, By 2025-2035 (USD Billion)
4.2.5. Trace Elements
4.2.5.1. Market Size and Forecast, By 2025-2035 (USD Billion)
4.2.6. Vitamins & Minerals
4.2.6.1. Market Size and Forecast, By 2025-2035 (USD Billion)
4.3. Enteral Feeding Formulas
4.3.1. Market Size and Forecast, By 2025-2035 (USD Billion)
4.3.2. Standard Formula
4.3.2.1. Market Size and Forecast, By 2025-2035 (USD Billion)
4.3.3. Disease-specific Formulas
4.3.3.1. Market Size and Forecast, By 2025-2035 (USD Billion)
5. Clinical Nutrition Market, Application Segment Analysis
5.1. Overview
5.1.1. Market Revenue Share, By Application, 2025 & 2035
5.1.2. Key Market Trends, Growth Factors, & Opportunities
5.2. Alzheimer’s Disease
5.2.1. Market Size and Forecast, By 2025-2035 (USD Billion)
5.3. Nutrition Deficiency
5.3.1. Market Size and Forecast, By 2025-2035 (USD Billion)
5.4. Cancer Care
5.4.1. Market Size and Forecast, By 2025-2035 (USD Billion)
5.5. Diabetes
5.5.1. Market Size and Forecast, By 2025-2035 (USD Billion)
5.6. Chronic Kidney Diseases
5.6.1. Market Size and Forecast, By 2025-2035 (USD Billion)
5.7. Orphan Diseases
5.7.1. Market Size and Forecast, By 2025-2035 (USD Billion)
5.8. Dysphagia
5.8.1. Market Size and Forecast, By 2025-2035 (USD Billion)
5.9. Pain Management
5.9.1. Market Size and Forecast, By 2025-2035 (USD Billion)
5.10. Digestive Malfunction/Intestinal Disorder/Diarrheal Conditions
5.10.1. Market Size and Forecast, By 2025-2035 (USD Billion)
5.11. Others
5.11.1. Market Size and Forecast, By 2025-2035 (USD Billion)
6. Clinical Nutrition Market, Age Group Segment Analysis
6.1. Overview
6.1.1. Market Revenue Share, By Age Group, 2025 & 2035
6.1.2. Key Market Trends, Growth Factors, & Opportunities
6.2. Pediatric
6.2.1. Market Size and Forecast, By 2025-2035 (USD Billion)
6.3. Adult
6.3.1. Market Size and Forecast, By 2025-2035(USD Billion)
6.4. Geriatrics
6.4.1. Market Size and Forecast, By 2025-2035 (USD Billion)
7. Clinical Nutrition Market, End User Segment Analysis
7.1. Overview
7.1.1. Market Revenue Share, By End User, 2025 & 2035
7.1.2. Key Market Trends, Growth Factors, & Opportunities
7.2. Hospitals
7.2.1. Market Size and Forecast, By 2025-2035 (USD Billion)
7.3. Retail Pharmacies
7.3.1. Market Size and Forecast, By 2025-2035 (USD Billion)
7.4. Online Pharmacies
7.4.1. Market Size and Forecast, By 2025-2035 (USD Billion)
7.5. Others
7.5.1. Market Size and Forecast, By 2025-2035 (USD Billion)
8. Clinical Nutrition Market, Region Segment Analysis
8.1. Overview
8.1.1. Global Market Revenue Share, By Region, 2025 & 2035
8.1.2. Global Market Revenue, By Region, 2025-2035(USD Billion)
8.2. North America
8.2.1. North America Market Revenue, By Country, 2025-2035(USD Billion)
8.2.2. North America Market Revenue, By Product Type, 2025-2035
8.2.3. North America Market Revenue, By Application, 2025-2035
8.2.4. North America Market Revenue, By Age Group, 2025-2035
8.2.5. North America Market Revenue, By End User, 2025-2035
8.2.6. The U.S.
8.2.6.1. U.S. Market Revenue, By Product Type, 2025-2035
8.2.6.2. U.S. Market Revenue, By Application, 2025-2035
8.2.6.3. U.S. Market Revenue, By Age Group, 2025-2035
8.2.6.4. U.S. Market Revenue, By End User, 2025-2035
8.2.7. Canada
8.2.7.1. U.S. Market Revenue, By Product Type, 2025-2035
8.2.7.2. U.S. Market Revenue, By Application, 2025-2035
8.2.7.3. U.S. Market Revenue, By Age Group, 2025-2035
8.2.7.4. U.S. Market Revenue, By End User, 2025-2035
8.3. Europe
8.3.1. Europe Market Revenue, By Country, 2025-2035(USD Billion)
8.3.2. Europe Market Revenue, By Product Type, 2025-2035
8.3.3. Europe Market Revenue, By Application, 2025-2035
8.3.4. Europe Market Revenue, By Age Group, 2025-2035
8.3.5. Europe Market Revenue, By End User, 2025-2035
8.3.6. Germany
8.3.6.1. Germany Market Revenue, By Product Type, 2025-2035
8.3.6.2. Germany Market Revenue, By Application, 2025-2035
8.3.6.3. Germany Market Revenue, By Age Group, 2025-2035
8.3.6.4. Germany Market Revenue, By End User, 2025-2035
8.3.7. France
8.3.7.1. France Market Revenue, By Product Type, 2025-2035
8.3.7.2. France Market Revenue, By Application, 2025-2035
8.3.7.3. France Market Revenue, By Age Group, 2025-2035
8.3.7.4. France Market Revenue, By End User, 2025-2035
8.3.8. U.K.
8.3.8.1. U.K. Market Revenue, By Product Type, 2025-2035
8.3.8.2. U.K. Market Revenue, By Application, 2025-2035
8.3.8.3. U.K. Market Revenue, By Age Group, 2025-2035
8.3.8.4. U.K. Market Revenue, By End User, 2025-2035
8.3.9. Italy
8.3.9.1. Italy Market Revenue, By Product Type, 2025-2035
8.3.9.2. Italy Market Revenue, By Application, 2025-2035
8.3.9.3. Italy Market Revenue, By Age Group, 2025-2035
8.3.9.4. Italy Market Revenue, By End User, 2025-2035
8.3.10. Spain
8.3.10.1. Spain Market Revenue, By Product Type, 2025-2035
8.3.10.2. Spain Market Revenue, By Application, 2025-2035
8.3.10.3. Spain Market Revenue, By Age Group, 2025-2035
8.3.10.4. Spain Market Revenue, By End User, 2025-2035
8.3.11. Rest of Europe
8.3.11.1. Rest of Europe Market Revenue, By Product Type, 2025-2035
8.3.11.2. Rest of Europe Market Revenue, By Application, 2025-2035
8.3.11.3. Rest of Europe Market Revenue, By Age Group, 2025-2035
8.3.11.4. Rest of Europe Market Revenue, By End User, 2025-2035
8.4. Asia Pacific
8.4.1. Asia Pacific Market Revenue, By Country, 2025-2035(USD Billion)
8.4.2. Asia Pacific Market Revenue, By Product Type, 2025-2035
8.4.3. Asia Pacific Market Revenue, By Application, 2025-2035
8.4.4. Asia Pacific Market Revenue, By Age Group, 2025-2035
8.4.5. Asia Pacific Market Revenue, By End User, 2025-2035
8.4.6. China
8.4.6.1. China Market Revenue, By Product Type, 2025-2035
8.4.6.2. China Market Revenue, By Application, 2025-2035
8.4.6.3. Canada Market Revenue, By Age Group, 2025-2035
8.4.6.4. Canada Market Revenue, By End User, 2025-2035
8.4.7. Japan
8.4.7.1. Japan Market Revenue, By Product Type, 2025-2035
8.4.7.2. Japan Market Revenue, By Application, 2025-2035
8.4.7.3. Japan Market Revenue, By Age Group, 2025-2035
8.4.7.4. Japan Market Revenue, By End User, 2025-2035
8.4.8. India
8.4.8.1. India Market Revenue, By Product Type, 2025-2035
8.4.8.2. India Market Revenue, By Application, 2025-2035
8.4.8.3. India Market Revenue, By Age Group, 2025-2035
8.4.8.4. India Market Revenue, By End User, 2025-2035
8.4.9. Australia
8.4.9.1. Australia Market Revenue, By Product Type, 2025-2035
8.4.9.2. Australia Market Revenue, By Application, 2025-2035
8.4.9.3. Australia Market Revenue, By Age Group, 2025-2035
8.4.9.4. Australia Market Revenue, By End User, 2025-2035
8.4.10. South Korea
8.4.10.1. South Korea Market Revenue, By Product Type, 2025-2035
8.4.10.2. South Korea Market Revenue, By Application, 2025-2035
8.4.10.3. South Korea Market Revenue, By Age Group, 2025-2035
8.4.10.4. South Korea Market Revenue, By End User, 2025-2035
8.4.11. Singapore
8.4.11.1. Singapore Market Revenue, By Product Type, 2025-2035
8.4.11.2. Singapore Market Revenue, By Application, 2025-2035
8.4.11.3. Singapore Market Revenue, By Age Group, 2025-2035
8.4.11.4. Singapore Market Revenue, By End User, 2025-2035
8.4.12. Rest of Asia Pacific
8.4.12.1. Rest of Asia Pacific Market Revenue, By Product Type, 2025-2035
8.4.12.2. Rest of Asia Pacific Market Revenue, By Application, 2025-2035
8.4.12.3. Rest of Asia Pacific Market Revenue, By Age Group, 2025-2035
8.4.12.4. Rest of Asia Pacific Market Revenue, By End User, 2025-2035
8.5. Latin America
8.5.1. Latin America Market Revenue, By Country, 2025-2035(USD Billion)
8.5.2. Latin America Market Revenue, By Product Type, 2025-2035
8.5.3. Latin America Market Revenue, By Application, 2025-2035
8.5.4. Latin America Market Revenue, By Age Group, 2025-2035
8.5.5. Latin America Market Revenue, By End User, 2025-2035
8.5.6. Brazil
8.5.6.1. Brazil Market Revenue, By Product Type, 2025-2035
8.5.6.2. Brazil Market Revenue, By Application, 2025-2035
8.5.6.3. Brazil Market Revenue, By Age Group, 2025-2035
8.5.6.4. Brazil Market Revenue, By End User, 2025-2035
8.5.7. Argentina
8.5.7.1. Brazil Market Revenue, By Product Type, 2025-2035
8.5.7.2. Brazil Market Revenue, By Application, 2025-2035
8.5.7.3. Brazil Market Revenue, By Age Group, 2025-2035
8.5.7.4. Brazil Market Revenue, By End User, 2025-2035
8.5.8. Mexico
8.5.8.1. Mexico Market Revenue, By Product Type, 2025-2035
8.5.8.2. Mexico Market Revenue, By Application, 2025-2035
8.5.8.3. Mexico Market Revenue, By Age Group, 2025-2035
8.5.8.4. Mexico Market Revenue, By End User, 2025-2035
8.5.9. Rest of Latin America
8.5.9.1. Rest of Latin America Market Revenue, By Product Type, 2025-2035
8.5.9.2. Rest of Latin America Market Revenue, By Application, 2025-2035
8.5.9.3. Rest of Latin America Market Revenue, By Age Group, 2025-2035
8.5.9.4. Rest of Latin America Market Revenue, By End User, 2025-2035
8.6. MEA
8.6.1. MEA Market Revenue, By Country, 2025-2035(USD Billion)
8.6.2. MEA Market Revenue, By Product Type, 2025-2035
8.6.3. MEA Market Revenue, By Application, 2025-2035
8.6.4. MEA Market Revenue, By Age Group, 2025-2035
8.6.5. MEA Market Revenue, By End User, 2025-2035
8.6.6. GCC Countries
8.6.6.1. GCC Countries Market Revenue, By Product Type, 2025-2035
8.6.6.2. GCC Countries Market Revenue, By Application, 2025-2035
8.6.6.3. GCC Countries Market Revenue, By Age Group, 2025-2035
8.6.6.4. GCC Countries Market Revenue, By End User, 2025-2035
8.6.7. South Africa
8.6.7.1. South Africa Countries Market Revenue, By Product Type, 2025-2035
8.6.7.2. South Africa Countries Market Revenue, By Application, 2025-2035
8.6.7.3. South Africa Countries Market Revenue, By Age Group, 2025-2035
8.6.7.4. South Africa Countries Market Revenue, By End User, 2025-2035
8.6.8. Rest of Middle-East Africa
8.6.8.1. Rest of Middle-East Africa Countries Market Revenue, By Product Type, 2025-2035
8.6.8.2. Rest of Middle-East Africa Countries Market Revenue, By Application, 2025-2035
8.6.8.3. Rest of Middle-East Africa Countries Market Revenue, By Age Group, 2025-2035
8.6.8.4. Rest of Middle-East Africa Countries Market Revenue, By End User, 2025-2035
9. Company Profile
9.1. Nestlé S.A.
9.1.1. Business Overview
9.1.2. Financial Performance
9.1.3. Product/Service Offerings
9.1.4. Strategies & recent developments
9.1.5. SWOT Analysis
9.2. Abbott Laboratories
9.2.1. Business Overview
9.2.2. Financial Performance
9.2.3. Product/Service Offerings
9.2.4. Strategies & recent developments
9.2.5. SWOT Analysis
9.3. Danone Nutricia
9.3.1. Business Overview
9.3.2. Financial Performance
9.3.3. Product/Service Offerings
9.3.4. Strategies & recent developments
9.3.5. SWOT Analysis
9.4. B. Braun Melsungen AG
9.4.1. Business Overview
9.4.2. Financial Performance
9.4.3. Product/Service Offerings
9.4.4. Strategies & recent developments
9.4.5. SWOT Analysis
9.5. Fresenius SE & Co. KGaA
9.5.1. Business Overview
9.5.2. Financial Performance
9.5.3. Product/Service Offerings
9.5.4. Strategies & recent developments
9.5.5. SWOT Analysis
9.6. Perrigo Company PLC
9.6.1. Business Overview
9.6.2. Financial Performance
9.6.3. Product/Service Offerings
9.6.4. Strategies & recent developments
9.6.5. SWOT Analysis
9.7. Pfizer Inc.
9.7.1. Business Overview
9.7.2. Financial Performance
9.7.3. Product/Service Offerings
9.7.4. Strategies & recent developments
9.7.5. SWOT Analysis
9.8. Lonza Ltd.
9.8.1. Business Overview
9.8.2. Financial Performance
9.8.3. Product/Service Offerings
9.8.4. Strategies & recent developments
9.8.5. SWOT Analysis
9.9. Baxter International Inc.
9.9.1. Business Overview
9.9.2. Financial Performance
9.9.3. Product/Service Offerings
9.9.4. Strategies & recent developments
9.9.5. SWOT Analysis
9.10. Hero Nutritionals Inc.
9.10.1. Business Overview
9.10.2. Financial Performance
9.10.3. Product/Service Offerings
9.10.4. Strategies & recent developments
9.10.5. SWOT Analysis
9.11. Mead Johnson Nutrition
9.11.1. Business Overview
9.11.2. Financial Performance
9.11.3. Product/Service Offerings
9.11.4. Strategies & recent developments
9.11.5. SWOT Analysis
9.12. Vivify Health
9.12.1. Business Overview
9.12.2. Financial Performance
9.12.3. Product/Service Offerings
9.12.4. Strategies & recent developments
9.12.5. SWOT Analysis
9.13. Meiji Holdings Co., Ltd.
9.13.1. Business Overview
9.13.2. Financial Performance
9.13.3. Product/Service Offerings
9.13.4. Strategies & recent developments
9.13.5. SWOT Analysis
9.14. Reckitt Benckiser
9.14.1. Business Overview
9.14.2. Financial Performance
9.14.3. Product/Service Offerings
9.14.4. Strategies & recent developments
9.14.5. SWOT Analysis
9.15. AYMES International Ltd
9.15.1. Business Overview
9.15.2. Financial Performance
9.15.3. Product/Service Offerings
9.15.4. Strategies & recent developments
9.15.5. SWOT Analysis
9.16. FMC Corporation
9.16.1. Business Overview
9.16.2. Financial Performance
9.16.3. Product/Service Offerings
9.16.4. Strategies & recent developments
9.16.5. SWOT Analysis
9.17. Ketogenic
9.17.1. Business Overview
9.17.2. Financial Performance
9.17.3. Product/Service Offerings
9.17.4. Strategies & recent developments
9.17.5. SWOT Analysis
9.18. Hershey (Hershey Nutrition)
9.18.1. Business Overview
9.18.2. Financial Performance
9.18.3. Product/Service Offerings
9.18.4. Strategies & recent developments
9.18.5. SWOT Analysis
9.19. GNC Holdings Inc.
9.19.1. Business Overview
9.19.2. Financial Performance
9.19.3. Product/Service Offerings
9.19.4. Strategies & recent developments
9.19.5. SWOT Analysis
9.20. Medtronic
9.20.1. Business Overview
9.20.2. Financial Performance
9.20.3. Product/Service Offerings
9.20.4. Strategies & recent developments
9.20.5. SWOT Analysis

ページTOPに戻る

List of Tables/Graphs

Tables
TABLE 1.GLOBAL CLINICAL NUTRITION MARKET VALUE, BY APPLICATION, 2022-2028 (USD BILLION)
TABLE 2.GLOBAL CLINICAL NUTRITION MARKET VALUE FOR ACTIVATED CARBON, BY GEOGRAPHY, 2022-2028 (USD BILLION)
TABLE 3.GLOBAL CLINICAL NUTRITION MARKET VALUE FOR CARBON DERIVATIVES, BY GEOGRAPHY, 2022-2028 (USD BILLION)
TABLE 4.GLOBAL CLINICAL NUTRITION MARKET VALUE FOR METAL OXIDES, BY GEOGRAPHY, 2022-2028 (USD BILLION)
TABLE 5.GLOBAL CLINICAL NUTRITION MARKET VALUE FOR CONDUCTIVE POLYMERS, BY GEOGRAPHY, 2022-2028 (USD BILLION)
TABLE 6.GLOBAL CLINICAL NUTRITION MARKET VALUE FOR OTHERS, BY GEOGRAPHY, 2022-2028 (USD BILLION)
TABLE 7.GLOBAL CLINICAL NUTRITION MARKET VALUE, BY END-USERS, 2022-2028 (USD BILLION)
TABLE 8.GLOBAL CLINICAL NUTRITION MARKET VALUE FOR CONSUMER ELECTRONICS, 2022-2028 (USD BILLION)
TABLE 9.GLOBAL CLINICAL NUTRITION MARKET VALUE FOR INDUSTRIAL, BY GEOGRAPHY, 2022-2028 (USD BILLION)
TABLE 10.GLOBAL CLINICAL NUTRITION MARKET VALUE FOR TRANSPORTATION, BY GEOGRAPHY, 2022-2028 (USD BILLION)
TABLE 11.GLOBAL CLINICAL NUTRITION MARKET VALUE FOR OTHERS, BY GEOGRAPHY, 2022-2028 (USD BILLION)
TABLE 12.NORTH AMERICA CLINICAL NUTRITION MARKET VALUE, BY COUNTRY, 2022-2028 (USD BILLION)
TABLE 13.NORTH AMERICA CLINICAL NUTRITION MARKET VALUE, BY APPLICATION, 2022-2028 (USD BILLION)
TABLE 14.NORTH AMERICA CLINICAL NUTRITION MARKET VALUE, BY END-USERS, 2022-2028 (USD BILLION)
TABLE 15.U.S CLINICAL NUTRITION MARKET VALUE, BY APPLICATION, 2022-2028 (USD BILLION)
TABLE 16.U.S CLINICAL NUTRITION MARKET VALUE, BY END-USERS, 2022-2028 (USD BILLION)
TABLE 17.CANADA CLINICAL NUTRITION MARKET VALUE, BY APPLICATION, 2022-2028 (USD BILLION)
TABLE 18.CANADA CLINICAL NUTRITION MARKET VALUE, BY END-USERS, 2022-2028 (USD BILLION)
TABLE 19.EUROPE CLINICAL NUTRITION MARKET VALUE, BY COUNTRY, 2022-2028 (USD BILLION)
TABLE 20.EUROPE CLINICAL NUTRITION MARKET VALUE, BY APPLICATION, 2022-2028 (USD BILLION)
TABLE 21.EUROPE CLINICAL NUTRITION MARKET VALUE, END-USERS, 2022-2028 (USD BILLION)
TABLE 22.GERMANY CLINICAL NUTRITION MARKET VALUE, BY APPLICATION, 2022-2028 (USD BILLION)
TABLE 23.GERMANY CLINICAL NUTRITION MARKET VALUE, BY END-USERS, 2022-2028 (USD BILLION)
TABLE 24.U.K CLINICAL NUTRITION MARKET VALUE, BY APPLICATION, 2022-2028 (USD BILLION)
TABLE 25.U.K CLINICAL NUTRITION MARKET VALUE, BY END-USERS, 2022-2028 (USD BILLION)
TABLE 26.FRANCE CLINICAL NUTRITION MARKET VALUE, BY APPLICATION, 2022-2028 (USD BILLION)
TABLE 27.FRANCE CLINICAL NUTRITION MARKET VALUE, BY END-USERS, 2022-2028 (USD BILLION)
TABLE 28.ITALY CLINICAL NUTRITION MARKET VALUE, BY APPLICATION, 2022-2028 (USD BILLION)
TABLE 29.ITALY CLINICAL NUTRITION MARKET VALUE, BY END-USERS, 2022-2028 (USD BILLION)
TABLE 30.SPAIN SUPERCAPACITOR MATERIALS MARKET VALUE, BY APPLICATION, 2022-2028 (USD BILLION)
TABLE 31.SPAIN SUPERCAPACITOR MATERIALS MARKET VALUE, BY END-USERS, 2022-2028 (USD BILLION)
TABLE 32.ROE CLINICAL NUTRITION MARKET VALUE, BY APPLICATION, 2022-2028 (USD BILLION)
TABLE 33.ROE CLINICAL NUTRITION MARKET VALUE, BY END-USERS, 2022-2028 (USD BILLION)
TABLE 34.ASIA PACIFC CLINICAL NUTRITION MARKET VALUE, BY COUNTRY, 2022-2028 (USD BILLION)
TABLE 35.ASIA PACIFC CLINICAL NUTRITION MARKET VALUE, BY APPLICATION, 2022-2028 (USD BILLION)
TABLE 36.ASIA PACIFC CLINICAL NUTRITION MARKET VALUE, BY END-USERS, 2022-2028 (USD BILLION)
TABLE 37.CHINA CLINICAL NUTRITION MARKET VALUE, BY APPLICATION, 2022-2028 (USD BILLION)
TABLE 38.CHINA CLINICAL NUTRITION MARKET VALUE, BY END-USERS, 2022-2028 (USD BILLION)
TABLE 39.INDIA CLINICAL NUTRITION MARKET VALUE, BY APPLICATION, 2022-2028 (USD BILLION)
TABLE 40.INDIA CLINICAL NUTRITION MARKET VALUE, BY END-USERS, 2022-2028 (USD BILLION)
TABLE 41.JAPAN CLINICAL NUTRITION MARKET VALUE, BY APPLICATION, 2022-2028 (USD BILLION)
TABLE 42.JAPAN CLINICAL NUTRITION MARKET VALUE, BY END-USERS, 2022-2028 (USD BILLION)
TABLE 43.REST OF APAC CLINICAL NUTRITION MARKET VALUE, BY APPLICATION, 2022-2028 (USD BILLION)
TABLE 44.REST OF APAC CLINICAL NUTRITION MARKET VALUE, BY END-USERS, 2022-2028 (USD BILLION)
TABLE 45.REST OF WORLD CLINICAL NUTRITION MARKET VALUE, BY APPLICATION, 2022-2028 (USD BILLION)
TABLE 46.REST OF WORLD CLINICAL NUTRITION MARKET VALUE, BY END-USERS, 2022-2028 (USD BILLION)
TABLE 47.CABOT(NORIT): FINANCIALS
TABLE 48.CABOT(NORIT): PRODUCTS & SERVICES
TABLE 49.CABOT(NORIT): RECENT DEVELOPMENTS
TABLE 50.KURARY CO. LTD: FINANCIALS
TABLE 51.KURARY CO. LTD: PRODUCTS & SERVICES
TABLE 52.KURARY CO. LTD: RECENT DEVELOPMENTS
TABLE 53.BAYER MATERIALSCIENCE AG: FINANCIALS
TABLE 54.BAYER MATERIALSCIENCE AG: PRODUCTS & SERVICES
TABLE 55.BAYER MATERIALSCIENCE AG: RECENT DEVELOPMENTS
TABLE 56.CALGON CARBON CORPORATION: FINANCIALS
TABLE 57.CALGON CARBON CORPORATION: PRODUCTS & SERVICES
TABLE 58.CALGON CARBON CORPORATION: RECENT DEVELOPMENTS
TABLE 59.CARBON NT&F: FINANCIALS
TABLE 60.CARBON NT&F: PRODUCTS & SERVICES
TABLE 61.CARBON NT&F: RECENT DEVELOPMENTS
TABLE 62.SHENZHEN NTP: FINANCIALS
TABLE 63.SHENZHEN NTP: PRODUCTS & SERVICES
TABLE 64.SHENZHEN NTP: RECENT DEVELOPMENTS
TABLE 65.CECA SA: FINANCIALS
TABLE 66.CECA SA: PRODUCTS & SERVICES
TABLE 67.CECA SA: RECENT DEVELOPMENTS
TABLE 68.CNANO TECHNOLOGY: FINANCIALS
TABLE 69.CNANO TECHNOLOGY: PRODUCTS & SERVICES
TABLE 70.CNANO TECHNOLOGY: RECENT DEVELOPMENTS
TABLE 71.DONAU CHEMIE GROUP: FINANCIALS
TABLE 72.DONAU CHEMIE GROUP: PRODUCTS & SERVICES
TABLE 73.DONAU CHEMIE GROUP: RECENT DEVELOPMENTS
TABLE 74.SHOWA DENKO: FINANCIALS
TABLE 75.SHOWA DENKO: PRODUCTS & SERVICES
TABLE 76.SHOWA DENKO: RECENT DEVELOPMENTS